Spotlight
Video

Dr. Rini on the Axitinib and Sorafenib Trial Hazard Ratio

onclivetv has 407 videos Subscribe Here

Loading........
Description: Brian Rini, MD, from the Cleveland Clinic Taussig Cancer Institute on the axitinib and sorafenib trial hazard ratio.
Shared By : onclivetv
Posted on : 06/27/11
Added : 6 years ago
Category : General



More From onclivetv

Nothing found.